6-Acetoxymethyl-1-[2-[(2,4-dimethylphenyl)thio]phenyl]-4-β-D-glucopyranosylpiperazine Triacetate is an intermediate in the synthesis of Vortioxetine Glucose Adduct (V766015), which is an impurity of Vortioxetine (V766000), a multimodal serotonergic agent that inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT (1,2,3).